Rapport Therapeutics Quote - RAPP

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

17.775

Bid

18.00

Ask

19.97

Volume

128,025

16.02 Day's Range 18.00

12.0948 52 Week Range 29.74

Market Cap

650.147M

Previous Close

16.60

Open

16.02

Last Trade

18.4

Last Trade Time

Financial Volume

US$ 2,218,883

VWAP

17.3316

Average Volume (3m)

114,321

Shares Outstanding

36,576,457

Dividend Yield

PE Ratio

-18.93

Earnings Per Share (EPS)

-0.95

Revenue

Net Profit

-34.79M

Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational sma... Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

New Castle, Delaware, USA

Founded

Rapport Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RAPP. The last closing price for Rapport Therapeutics was US$16.60. Over the last year, Rapport Therapeutics shares have traded in a share price range of US$ 12.0948 to US$ 29.74.

Rapport Therapeutics currently has 36,576,457 shares outstanding. The market capitalization of Rapport Therapeutics is US$607.17 million. Rapport Therapeutics has a price to earnings ratio (PE ratio) of -18.93.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

BOSTON and SAN DIEGO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Rapport Therapeutics, Inc. (Nasdaq: RAPP), please note the references to the...

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing Phase 2a trial in focal epilepsy; restricted...

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

A 30% reduction in long episodes was shown to be associated with a 50% or greater reduction in clinical seizures in a post-hoc analysis, validating the biomarker for proof-of-concept studies...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	4.165	30.6024981631	13.61	18	13.13	102880	16.11342639	CS
4	-0.225	-1.25	18	18.25	12.0948	104434	14.73374576	CS
12	-8.745	-32.9751131222	26.52	27.26	12.0948	114321	18.70997641	CS
26	-3.225	-15.3571428571	21	29.74	12.0948	130539	20.45765534	CS
52	-0.225	-1.25	18	29.74	12.0948	148079	21.33485389	CS
156	-0.225	-1.25	18	29.74	12.0948	148079	21.33485389	CS
260	-0.225	-1.25	18	29.74	12.0948	148079	21.33485389	CS

RAPP - Frequently Asked Questions (FAQ)

What is the current Rapport Therapeutics share price?

The current share price of Rapport Therapeutics is US$ 17.775

How many Rapport Therapeutics shares are in issue?

Rapport Therapeutics has 36,576,457 shares in issue

What is the market cap of Rapport Therapeutics?

The market capitalisation of Rapport Therapeutics is USD 607.17M

What is the 1 year trading range for Rapport Therapeutics share price?

Rapport Therapeutics has traded in the range of US$ 12.0948 to US$ 29.74 during the past year

What is the PE ratio of Rapport Therapeutics?

The price to earnings ratio of Rapport Therapeutics is -18.93

What is the reporting currency for Rapport Therapeutics?

Rapport Therapeutics reports financial results in USD

What is the latest annual profit for Rapport Therapeutics?

The latest annual profit of Rapport Therapeutics is USD -34.79M

What is the registered address of Rapport Therapeutics?

The registered address for Rapport Therapeutics is 1209 ORANGE STREET, IN THE CITY OF WILMINGTON, NEW CASTLE, DELAWARE, 19801

Which industry sector does Rapport Therapeutics operate in?

Rapport Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
QNTMQuantum Biopharma Ltd	US$ 6.70 (110.69%)	78.56M
LTRYLottery com Inc	US$ 0.58 (85.90%)	129.21M
CPIXCumberland Pharmaceutical Inc	US$ 3.7801 (77.47%)	18.49M
INKTMiNK Therapeutics Inc	US$ 12.08 (53.69%)	350.86k
OMGAOmega Therapeutics Inc	US$ 0.1473 (-69.25%)	11.71M
VIRXViracta Therapeutics Inc	US$ 0.0352 (-54.76%)	6.33M
CYNCYNGN Inc	US$ 0.0708 (-39.44%)	137.42M
UPCUniverse Pharmaceuticals Inc	US$ 0.2663 (-36.20%)	1.9M
CSAICloudastructure Inc	US$ 12.98 (-31.68%)	57.03k
NVDANVIDIA Corporation	US$ 118.65 (1.71%)	247.88M
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	245.99M
PLTRPalantir Technologies Inc	US$ 103.83 (23.99%)	212.8M
RGTIRigetti Computing Inc	US$ 13.71 (1.78%)	150.63M
CYNCYNGN Inc	US$ 0.0708 (-39.44%)	134.64M